Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Detection of outlying data in bioavailability/bioequivalence studies.

J P Liu1, C S Weng

  • 1Berlex Laboratories, Inc., Wayne, NJ 07470.

Statistics in Medicine
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrine inhibits the proliferation, migration, invasion, and stemness of thymoma cells by regulating the Wnt3a/Β-catenin pathway.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same author

[Type 2 autoimmune pancreatitis: a clinicopathological analysis].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2025
Same author

[Herpetic esophagitis: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2025
Same author

[Diagnostic and intervention value of implantable cardiac monitor in patients over 60 years of age with unexplained syncope].

Zhonghua xin xue guan bing za zhi·2024
Same author

[Multicenter evaluation of the diagnostic efficacy of jaundice color card for neonatal hyperbilirubinemia].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2024
Same author

[Clinical features and lymphocyte subtypes in patients with IgG<sub>4</sub>-related diseases].

Zhonghua nei ke za zhi·2024

This study introduces novel statistical methods to identify outlying subjects and observations in bioavailability/bioequivalence studies, enhancing data integrity for drug development.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Biostatistics
  • Drug Development and Regulatory Science

Background:

  • Accurate data analysis is crucial in bioavailability/bioequivalence (BBE) studies for drug approval.
  • Identifying outlying data points (subjects or observations) is essential to prevent biased study outcomes.
  • Existing methods may not adequately address the complexities of BBE data, including formulation covariance and multiplicity.

Purpose of the Study:

  • To propose and validate statistical procedures for detecting outlying subjects and observations in BBE studies.
  • To enhance the reliability and interpretability of BBE study results.
  • To provide robust methods that account for the specific statistical characteristics of BBE data.

Main Methods:

  • Development of two distinct statistical test procedures.

Related Experiment Videos

  • Procedure 1: Utilizes a two-sample Hotelling T2 statistic to detect outlying subjects.
  • Procedure 2: Employs residuals from formulation means to identify outlying observations within subjects.
  • Incorporation of covariance structure, test statistic dependence, and multiplicity adjustments.
  • Validation via Monte Carlo or bootstrap simulations to assess sampling distributions.

    • Main Results:

    • The proposed methods effectively identify outlying subjects and observations in simulated and real BBE data.
    • The statistical procedures demonstrate robustness in accounting for complex data dependencies.
    • Simulation results confirm the accuracy of the test statistics' sampling distributions.

    Conclusions:

    • The developed statistical tests provide reliable tools for identifying outliers in BBE studies.
    • These methods contribute to more accurate and trustworthy assessments of drug product equivalence.
    • Application in a 3-way crossover study illustrates the practical utility of the proposed procedures.